Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T06:35:24.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed information about a Phase II clinical trial for a combination treatment of prostate cancer, while adding references to collaborators and a new version revision.
    Difference
    56%
    Check dated 2025-04-16T23:18:38.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T17:21:36.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect the completion of a new version, v2.14.3, replacing the previous version v2.14.2. Additionally, the status has changed from 'Active, not recruiting' to a completed state.
    Difference
    0.2%
    Check dated 2025-04-02T02:39:25.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-03-04T07:42:18.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1.0%
    Check dated 2025-02-11T01:48:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.